RxDoctor Payments DataLook up a doctor →

Daniel Shivapour, MD

Interventional Cardiology · Des Moines, IANPI 1336376870

Payments from drug & device makers

$134,840in general payments, 2019–2025

Across 579 payments — averaging $232.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$44K
  • Astrazeneca UK Limited$42K
  • AstraZeneca$38K
  • Abbott$4K
  • Medtronic$2K
  • Shockwave Medical, Inc$877
  • plus $4K from 19 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$134,840 in reported general payments places this provider in the 85th percentile of 64 interventional cardiology providers in Iowa.

See all interventional cardiology providers in Iowa

Medicare billing

Part B allowed, 2024
$138,949
Medicare patients
514
Services billed
1,080

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →